Induction of plasminogen in rat hippocampal pyramidal neurons by kainic acid

Neurosci Lett. 1998 Aug 14;252(2):119-22. doi: 10.1016/s0304-3940(98)00562-x.

Abstract

Tissue plasminogen activator (tPA) is used to treat acute stroke, but tPA- and plasminogen-gene-deficient mice exhibit resistance to neurodegeneration. Thus, it is unclear whether the tPA-plasminogen system, an extracellular proteolytic cascade plays a helpful or harmful role, and whether plasminogen is induced by neurodegeneration. In the CA3, kainic acid (KA)-injection caused neuronal damage after 6 h, and almost all of the neurons were lost after 7 days. Plasminogen mRNA was strongly induced 6 h after injection, then gradually decreased, and was very weak at 2 days after injection. Plasminogen protein was expressed after 6 h and localized in abnormally shaped neurons. The in vivo expression of plasminogen was synchronous with morphological changes in neurons. These results suggest that the expression of plasminogen induced by KA-injection may disrupt of neuron-extracellular matrix interaction and thereby contribute to cell death in neurons in the hippocampus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies
  • Excitatory Amino Acid Agonists*
  • Extracellular Matrix / chemistry
  • Extracellular Matrix / metabolism
  • Fibrinolysin / metabolism
  • Gene Expression / drug effects
  • Hippocampus / chemistry
  • Hippocampus / cytology
  • Hippocampus / physiology*
  • Kainic Acid*
  • Male
  • Nerve Degeneration / metabolism
  • Plasminogen / analysis
  • Plasminogen / genetics*
  • Plasminogen / immunology
  • Plasminogen Activators / metabolism
  • Pyramidal Cells / chemistry
  • Pyramidal Cells / physiology*
  • RNA, Messenger / analysis
  • Rats
  • Rats, Wistar

Substances

  • Antibodies
  • Excitatory Amino Acid Agonists
  • RNA, Messenger
  • Plasminogen
  • Plasminogen Activators
  • Fibrinolysin
  • Kainic Acid